These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19638584)

  • 1. Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.
    Muders MH; Zhang H; Wang E; Tindall DJ; Datta K
    Cancer Res; 2009 Aug; 69(15):6042-8. PubMed ID: 19638584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells.
    Huang YL; Lin YC; Lin CC; Chen WM; Chen BPC; Lee H
    Cell Physiol Biochem; 2018; 50(2):597-611. PubMed ID: 30317243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo.
    Dormond O; Contreras AG; Meijer E; Datta D; Flynn E; Pal S; Briscoe DM
    J Immunol; 2008 Dec; 181(11):8088-95. PubMed ID: 19018001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostate cancer.
    Zhang H; Muders MH; Li J; Rinaldo F; Tindall DJ; Datta K
    Cancer Res; 2008 Nov; 68(21):8770-8. PubMed ID: 18974119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated vascular endothelial growth factor-C reduction suppresses malignant progression and enhances mitomycin C sensitivity of bladder cancer T24 cells.
    Zhang HH; Qi F; Shi YR; Miao JG; Zhou M; He W; Chen MF; Li Y; Zu XB; Qi L
    Cancer Biother Radiopharm; 2012 Jun; 27(5):291-8. PubMed ID: 21902544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance.
    Stanton MJ; Dutta S; Zhang H; Polavaram NS; Leontovich AA; Hönscheid P; Sinicrope FA; Tindall DJ; Muders MH; Datta K
    Cancer Res; 2013 Jan; 73(1):160-71. PubMed ID: 23149913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.
    Tuomela J; Valta M; Seppänen J; Tarkkonen K; Väänänen HK; Härkönen P
    BMC Cancer; 2009 Oct; 9():362. PubMed ID: 19821979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
    Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
    Chen H; Guan R; Lei Y; Chen J; Ge Q; Zhang X; Dou R; Chen H; Liu H; Qi X; Zhou X; Chen C
    BMC Cancer; 2015 Mar; 15():103. PubMed ID: 25884175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.
    Favier B; Alam A; Barron P; Bonnin J; Laboudie P; Fons P; Mandron M; Herault JP; Neufeld G; Savi P; Herbert JM; Bono F
    Blood; 2006 Aug; 108(4):1243-50. PubMed ID: 16621967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C.
    Sapoznik S; Cohen B; Tzuman Y; Meir G; Ben-Dor S; Harmelin A; Neeman M
    Cancer Res; 2009 Dec; 69(24):9306-14. PubMed ID: 19934313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.